AARTIPHARM
Invest Now
Start SIP in
AARTIPHARM
Performance
- Low
- ₹706
- High
- ₹744
- 52 Week Low
- ₹488
- 52 Week High
- ₹837
- Open Price₹716
- Previous Close₹712
- Volume460,224
Investment Returns
- Over 1 Month -3.17%
- Over 3 Month + 15.35%
- Over 6 Month + 25.1%
- Over 1 Year + 42.9%
Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!
Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26.8
- PEG Ratio
- 1
- Market Cap Cr
- 6,679
- P/B Ratio
- 3.6
- Average True Range
- 42.62
- EPS
- 27.51
- Dividend Yield
- 0.5
- MACD Signal
- -7.53
- RSI
- 53.11
- MFI
- 50.88
Aarti Pharmalabs Financials
Aarti Pharmalabs Technicals
EMA & SMA
Current Price
₹737.00
+
25.05
(3.52%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹717.62
- 50 Day
- ₹714.62
- 100 Day
- ₹693.30
- 200 Day
- ₹653.31
Resistance and Support
729.03
- R3 789.87
- R2 766.93
- R1 751.97
- S1 714.07
- S2 691.13
- S3 676.17
Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-05 | Quarterly Results, Dividend & Others | To consider other business matters. per share(40%)Interim Dividend |
2024-10-28 | Quarterly Results | |
2024-08-05 | Quarterly Results | |
2024-05-13 | Audited Results & Final Dividend | |
2024-02-07 | Quarterly Results & Interim Dividend |
Aarti Pharmalabs F&O
About Aarti Pharmalabs
- NSE Symbol
- AARTIPHARM
- BSE Symbol
- 543748
- Managing Director
- Mr. Narendra J Salvi
- ISIN
- INE0LRU01027
Similar Stocks to Aarti Pharmalabs
Aarti Pharmalabs FAQs
Aarti Pharmalabs share price is ₹737 As on 24 April, 2025 | 06:32
The Market Cap of Aarti Pharmalabs is ₹6679.1 Cr As on 24 April, 2025 | 06:32
The P/E ratio of Aarti Pharmalabs is 26.8 As on 24 April, 2025 | 06:32
The PB ratio of Aarti Pharmalabs is 3.6 As on 24 April, 2025 | 06:32
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.